1. N-acetyl-L: -cysteine reduces the parasitism of BALB/c mice infected with Leishmania amazonensis.
- Author
-
Monteiro MC, Marques FC, Blazius RD, Santos da Silva O, de Queiroz Cunha F, Bento DB, and Torres Romão PR
- Subjects
- Animals, Female, Foot parasitology, Foot pathology, Leishmania classification, Leishmania isolation & purification, Leishmania pathogenicity, Leishmaniasis, Cutaneous pathology, Lymph Nodes metabolism, Lymph Nodes parasitology, Mice, Mice, Inbred BALB C, Spleen metabolism, Treatment Outcome, Acetylcysteine administration & dosage, Glutathione metabolism, Leishmania drug effects, Leishmaniasis, Cutaneous drug therapy, Leishmaniasis, Cutaneous parasitology
- Abstract
Leishmania amazonensis infection leads to progressive diseases in a majority of inbred strains of mice. Glutathione (GSH) participates in a large number of cellular phenomena and seems to be essential for several immune functions, including host defense during leishmaniasis. In this study, we evaluated the effects of N-acetyl-L: -cysteine (NAC), as GSH supplement, on the course of L. amazonensis infection in susceptible BALB/c mice. The treatment with NAC (200 mg/kg daily) was effective in raising GSH levels in both lymph node and spleen cells. Although this treatment did not change the footpad swelling development in L. amazonensis-infected mice, it caused a significant decrease in the number of parasites recovered from the footpad lesion and draining popliteal lymph node. Our data suggest that intracellular Leishmania killing in vivo was improved by the augment of GSH levels through NAC administration.
- Published
- 2008
- Full Text
- View/download PDF